Kedrion’s global portfolio expands to China
Jun 26, 2023 |
CORPORATE
BPL’s Human Albumin is our first ever product approved in the Chinese market
IPPC 2023: Kedrion alongside PPTA
Jun 21, 2023 |
EVENTS
Kedrion Biopharma joins 2023 World Hemophilia Day
Apr 17, 2023 |
EVENTS
The company alongside the medical-scientific and patients communities
Kedrion presented at plasma fractionation workshop in Saudi Arabia
Mar 20, 2023 |
EVENTS
An opportunity to share our knowledge and long-standing experience in this industry
Kedrion awarded national tender for Portuguese plasma manufacturing
Mar 02, 2023 |
CORPORATE
First shipments of plasma from Porto and Lisbon were received in the beginning of February
Kedrion Biopharma joins Rare Disease Day
Feb 24, 2023 |
EVENTS
Raising awareness and generating change for the people living with a rare disease
The Fifth John Gorman Lectureship at the BIRTH 2022 Congress
Dec 09, 2022 |
EVENTS
These Conferences in Transfusion Medicine are made possible thanks to the unconditional support of Kedrion Biopharma
Kedrion strengthens its network of plasma collection centers
Dec 05, 2022 |
CORPORATE
Five centers acquired in the Czech Republic
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Sep 01, 2022 |
CORPORATE
Announced appointment of Ugo Di Francesco as CEO
